# Dicerna Pharmaceuticals Inc

Dicerna Pharmaceuticals Inc is a company headquartered in Lexington, MA, United States.

## Company overview

- **Legal name:** Dicerna Pharmaceuticals Inc
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Lexington, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001399529

## About

Dicerna Pharmaceuticals Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001399529, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-02-26, it reported annual revenue of USD 164,307,000; net income of USD -112,747,000; total assets of USD 707,846,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $164.3M (USD 164,307,000)
- **Net income:** -$112.7M (USD -112,747,000)
- **Total assets:** $707.8M (USD 707,846,000)
- **Cash and equivalents:** $126.0M (USD 126,023,000)
- **Operating cash flow:** $175.1M (USD 175,112,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $23.9M (USD 23,904,000)
- **Net income:** -$120.5M (USD -120,459,000)
- **Total assets:** $597.4M (USD 597,409,000)
- **Cash and equivalents:** $152.8M (USD 152,816,000)
- **Operating cash flow:** -$692,000 (USD -692,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $6.2M (USD 6,176,000)
- **Net income:** -$88.9M (USD -88,853,000)
- **Total assets:** $409.0M (USD 409,041,000)
- **Cash and equivalents:** $54.2M (USD 54,239,000)
- **Operating cash flow:** $18.3M (USD 18,298,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $2.3M (USD 2,277,000)
- **Net income:** -$60.0M (USD -60,048,000)
- **Total assets:** $120.9M (USD 120,884,000)
- **Cash and equivalents:** $68.8M (USD 68,789,000)
- **Later filings:** Net income, Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2021-12-28 — period 2021-12-28 — 8-K
- Form SC 13G — filed 2021-12-03 — SC 13G
- Form 8-K — filed 2021-11-18 — period 2021-11-17 — 8-K
- Form 10-Q — filed 2021-11-09 — period 2021-09-30 — 10-Q
- Form 8-K — filed 2021-11-09 — period 2021-11-09 — 8-K
- Form 10-Q — filed 2021-08-09 — period 2021-06-30 — 10-Q
- Form 8-K — filed 2021-08-09 — period 2021-08-09 — 8-K
- Form 8-K — filed 2021-08-06 — period 2021-08-05 — 8-K
- Form 8-K — filed 2021-06-04 — period 2021-06-03 — 8-K
- Form 10-Q — filed 2021-05-06 — period 2021-03-31 — 10-Q
- Form 8-K — filed 2021-05-06 — period 2021-05-06 — 8-K
- Form DEF 14A — filed 2021-04-20 — period 2021-06-03 — DEF 14A

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/dicerna-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology